american academy of cardiology glp 1 BJD AHA/ACC CKM Guideline Formally Endorses

Recent developments underscore the relevance of GLP-1R agonists in addressing the complex interplay of cardiovascular-kidney-metabolic (CKM) syndrome, microvascular dysfunction, and metabolic-associated steatohepatitis (MASH)

The incretin effect is defined as the higher stimulation of insulin secretion obtained when glucose is administered orally than intravenously, under similar plasma glucose levels

Expert guidance on keeping weight off and achieving long-term GLP-1 success.

Who This Is For: Anyone following a GLP-1 weight loss approach

Semaglutide patent expiry in mid-March 2026 set to trigger entry of 50+ branded generics in India: Sheetal Sapale

The global Obesity Medicines market reached $66 billion in list price sales value in 2025, according to IQVIAs ForecastLink, and is forecast to rise to $92 billion in 2026, before reaching between $105 billion and $200 billion by 2027 and beyond